Laboratory of Biotechnology, Integrated Bioscience Section, Graduate School of Science and Technology, Shizuoka University, 836 Ohya, Shizuoka 422-8529, Japan.
J Biotechnol. 2013 May 10;165(1):69-75. doi: 10.1016/j.jbiotec.2013.02.013. Epub 2013 Mar 16.
Virus-like particles (VLPs) displaying antigen have been increasingly recognized as a potential vaccine in the livestock industry. In this study, Neospora caninum surface protein related sequence (NcSRS)2 was displayed on the surface of Rous sarcoma virus group-antigen protein (RSV-gag) VLPs. Two types of Bombyx mori nucleopolyhedrovirus (BmNPV) bacmids, encoding RSV-gag and NcSRS2 genes, were co-injected into silkworm larvae to produce VLPs-NcSRS2. At 7 days post-injection, VLPs-NcSRS2 were collected from hemolymph and purified. The antigenicity of the purified protein was confirmed by enzyme-linked immunosorbent assay (ELISA) using neosporosis-positive bovine serum. ELISA revealed that ~0.16μg rNcSRS2 was displayed per 1μg VLPs-NcSRS2. To develop an antibody specific for VLPs-NcSRS2, purified VLPs-NcSRS2 were used to immunize mice in a three-dose regimen without adjuvant and the production of antibodies was confirmed in serum samples. By using a silkworm expression system, we demonstrated the display, expression and immunization of neosporosis-targeting membrane proteins, which are vaccine candidates for neosporosis.
病毒样颗粒(VLPs)展示抗原已逐渐被认可为畜牧业中的一种潜在疫苗。在本研究中,刚地弓形虫表面蛋白相关序列(NcSRS)2 被展示在 Rous 肉瘤病毒群抗原蛋白(RSV-gag)VLPs 的表面。两种类型的家蚕核型多角体病毒(BmNPV) bacmid,编码 RSV-gag 和 NcSRS2 基因,被共同注射到家蚕幼虫中以产生 VLPs-NcSRS2。在注射后 7 天,从血液中收集 VLPs-NcSRS2 并进行纯化。通过使用阳性牛血清的酶联免疫吸附试验(ELISA)来确认纯化蛋白的抗原性。ELISA 显示,每 1μg VLPs-NcSRS2 中展示了约 0.16μg rNcSRS2。为了开发针对 VLPs-NcSRS2 的抗体,使用纯化的 VLPs-NcSRS2 对无佐剂的小鼠进行了三剂量免疫,并在血清样本中确认了抗体的产生。通过使用家蚕表达系统,我们展示了针对刚地弓形虫的靶向膜蛋白的展示、表达和免疫,这些蛋白是刚地弓形虫病疫苗的候选物。